RF Industries, Ltd. — FY2022 Form 10-K Summary
Period: Fiscal year ended October 31, 2022, compared with fiscal 2021. The request metadata says “2021 Q4,” but the filing is an annual report for FY2022; it does not provide a standalone fourth-quarter summary.
Business context
RF Industries designs, manufactures and markets RF connectors and components, cable assemblies, fiber-optic and custom cabling, wiring harnesses, telecom cooling systems and small-cell enclosures. It reports two segments: RF Connector and Cable Assembly, and Custom Cabling Manufacturing and Assembly. Microlab, acquired March 1, 2022, was added to the RF Connector segment.
Financial results and liquidity
| Metric | FY2022 | FY2021 |
|---|---|---|
| Net sales | $85.3 million | $57.4 million |
| Gross profit / margin | $24.5 million / 28.8% | $17.8 million / 30.9% |
| Operating income / margin | $2.2 million / 2.6% | $4.4 million / 7.7% |
| Net income | $1.4 million | $6.2 million |
| Diluted EPS | $0.14 | $0.61 |
| Cash from operating activities | $2.9 million | $(3.1) million |
| Capital expenditures | $2.7 million | $0.2 million |
- Revenue rose 48%. The RF Connector segment generated $31.2 million, up from $15.6 million; Custom Cabling generated $54.1 million, up from $41.8 million. Microlab contributed $14.4 million in reported-period sales. Custom Cabling growth chiefly reflected project work on hybrid fiber cables for 4G/5G network builds.
- Gross margin was 28.8%, versus 30.9% reported in FY2021. The filing says FY2021 gross margin excluding the Employee Retention Credit (ERC) was 26.4%; on that adjusted comparison, FY2022 margin improved. FY2021 ERC also affected expenses, so reported year-over-year comparisons include this unusual item.
- Operating income declined despite higher sales, as engineering and selling and general expenses increased. FY2022 included $1.5 million of acquisition-related and other one-time charges, plus Microlab expenses and lease-related costs.
- Operating cash flow improved to $2.9 million, but cash and cash equivalents fell to $4.5 million from $13.1 million. Inventory increased $9.9 million to $21.1 million. The company spent $24.4 million on Microlab, partly funded by the term loan.
- At year-end, working capital was $26.7 million, current assets were $46.2 million and current liabilities were $19.5 million; the reported current ratio was approximately 2.4:1. Backlog fell to $27.8 million from $33.3 million.
- The $17 million term loan carries a 3.76% rate and matures March 1, 2027. The company had repaid $1.4 million by year-end; the balance sheet reports $2.4 million current and $13.1 million long-term, net of debt issuance costs. No revolving-credit borrowings were outstanding; the facility provides up to $3 million and matures March 1, 2024.
- Operating lease liabilities totaled $16.9 million, including $1.9 million current. Stockholders’ equity was $41.9 million, versus $39.6 million.
Material changes and unusual items
- The $24.5 million Microlab acquisition was funded with $17 million of term debt and approximately $7.3 million of cash on hand, plus a post-closing adjustment. The acquisition materially increased goodwill, intangible assets and lease commitments.
- FY2021 other income included forgiveness of approximately $2.8 million of Paycheck Protection Program loans. FY2022 other expense was $0.6 million, chiefly term-loan interest and a $0.2 million foreign-exchange loss.
- The company had a $1.6 million ERC receivable at year-end and received a $1.2 million refund in January 2023. It also recorded $2.8 million of tenant-improvement reimbursements in other current assets.
- There is a tax-rate inconsistency in the filing: MD&A cites an FY2022 effective rate of 8.8%, while the financial statements and tax note report 9.2%.
Outlook, commentary and risks
Management provided no specific revenue or earnings guidance. It said existing assets, expected operating cash generation and backlog should be sufficient to meet liquidity needs for the next 12 months. It intends to pursue organic growth and consider further acquisitions. Management described a generally more normal operating environment than during the earlier pandemic period, while noting continuing intermittent workforce effects and macroeconomic pressures.
- Key risks include dependence on wireless and broadband markets and customer capital spending; supply-chain and shipping disruptions, particularly for Asian contract manufacturing; inflation in materials, labor and freight; and limited ability to pass cost increases through fixed-price or longer-term contracts.
- A wireless carrier represented about 20% of FY2022 sales and 14% of year-end receivables. A distributor accounted for 19% of receivables. Major customer agreements have no minimum purchase obligations.
- The credit facility is secured by company and subsidiary personal property and includes financial covenants, including maximum debt-to-EBITDA of 3.00:1 and minimum fixed-charge coverage of 1.25:1. A covenant breach or default could expose the company to acceleration or collateral enforcement.
- Backlog is not necessarily predictive of future demand: orders can be delayed or cancelled, and most RF Connector orders have short lead times. Goodwill and acquired intangible valuations also depend on estimates and future performance; no impairment was recorded for FY2022.
- The company reported internal controls as effective, but Microlab was excluded from management’s FY2022 internal-control assessment while integration continued. The independent auditor did not attest to internal-control effectiveness.
- No material non-routine legal proceeding was reported. No dividends were paid in FY2022, and the board had terminated dividend payments.
Important facts for investors to verify
- Microlab’s post-acquisition sales, margins and cash contribution, and whether expected integration and growth benefits materialize.
- Cash conversion and working-capital needs, particularly inventory growth, and progress in converting the $27.8 million backlog into shipped orders and collections.
- Debt repayment, covenant headroom and liquidity after the acquisition, including lease obligations and the availability of the undrawn revolver.
- Exposure to major customers and suppliers, and the extent to which inflation, freight and supply disruptions affect pricing and gross margins.
- The FY2022 effective tax rate discrepancy and the final treatment of the ERC receivable and tenant-improvement reimbursements.
- Microlab integration controls and the remaining purchase-price allocation; the filing describes that allocation as preliminary.